Perio Treatment & Cerebrovascular Function
- Conditions
- Periodontitis
- Interventions
- Procedure: periodontal treatment
- Registration Number
- NCT05506917
- Lead Sponsor
- University of Santiago de Compostela
- Brief Summary
Periodontitis has been linked to increased risk of cerebrovascular disease. Impaired brain hemodynamics has been suggested as early markers of cerebral macro and microangiopathy. Therefore, the aim of this clinical trial will be to assess the potential effect of periodontal treatment on cerebral hemodynamics in otherwise healthy patients with severe periodontitis over 6 months.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Otherwise healthy subjects with severe periodontitis.
- <10 teeth
- current smokers
- undergo periodontal treatment within the last 6 months.
- receive antibiotics or anti-inflammatory drugs within the last 3 months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Periodontal treatment group periodontal treatment Patients will receive an intensive (non surgical) regimen of scaling and root planing of the root surfaces under local analgesia (depending on the severity in one session or two sessions within 2 days). Any tooth that from the baseline examination is defined as hopeless or irrational to treat will be extracted at the oral hygiene visit. After the 2 months re-assessment individuals if presenting with at least one periodontal pocket of 6 mm in depth will undergo additional corrective periodontal therapy consisting of periodontal surgery and re-instrumentation under local analgesia. If surgical periodontal therapy is not indicated, appropriate re-instrumentation of the sites will be performed.
- Primary Outcome Measures
Name Time Method Cerebrovascular reactivity (CvR) (%) Baseline-6 months CvR to hypercapnia was evaluated by means of the breath-holding index (BHI). Two dual 2-MHz transducers fitted on a headband and placed on the temporal bone windows were used to obtain a bilateral continuous measurement of mean flow velocity in the middle cerebral arteries. Depth of insonation ranged from 48 to 52 mm. The BHI is obtained by dividing the percentage increase in mean flow velocity occurring during breath holding by the length of time (seconds) subjects hold their breath af- ter a normal inspiration (\[mean flow velocity at the end of breath holding minus mean flow velocity at rest divided by mean flow velocity at rest\] multipled by 100 divided by seconds of breath holding).
- Secondary Outcome Measures
Name Time Method Pulsatility index Baseline-6 months Gosling's pulsatility index (PI) of the middle cerebral artery will be calculated according to the following formula: PI = (Vmax -Vmin)/Vmean
Resistivity index Baseline-6 months Resistivity index (RI) of the middle cerebral artery will be calculated according to the following formula: RI = (Vmax -Vmin)/Vmax
Serum high sensitivity C-reactive protein (hs-CRP) Baseline-6 months Levels of hs-CRP in serum will be measured by ELISA (mg/L)
Brachial flow-mediated dilatation Baseline-6 months After detection of brachial artery vasomotion, ultrasound evaluation will be made on the dominant forearm. Two- dimensional brachial artery imaging and measurements were performed in all patients by the same operator. Straight segments of the artery will be chosen above the antecubital fosse, perpendicular to the ultrasound beam and along its long axis. Flow-mediated dilatation caused by shear-induced endothelial nitric oxide production will be detected after occlusion of the forearm circulation. A longitudinal image will be used to measure brachial artery diameter; a blood pressure cuff will be inflated on the upper arm to 300 mmHg for 4 min and then deflated, and after 45 s to 1 min, a second longitudinal scan will be obtained, to calculate the brachial artery diameter.
Carotid intima-media thickness Baseline-6 months The image will be focused on the posterior (far) wall of the left carotid artery. A minimum of four measurements of the common carotid far wall was taken 10 mm proximal to the bifurcation, to derive the mean carotid intima-media thickness. The presence of an atheroma plaque will be evaluated in the common and internal carotid extracranial arteries as well as the bifurcations according to standardized scanning and reading protocols. Plaque will be defined as a focal structure that encroaches into the arterial lumen at least 0.5 mm or 50% of the surrounding intima-media thickness value, or demonstrates a thickness \>1.5 mm as measured from the media-adventitia interface to the intima- lumen interface.
Probing pocket depth Baseline-3 months-6 months Will be measured from the free gingival margin to the bottom of the sulcus or pocket (in mm)
Clinical attachment level Baseline-3 months-6 months measured from the cemento-enamel junction (CEJ) to the bottom of the sulcus or pocket (in mm)
Full-mouth bleeding score Baseline-3 months-6 months Defined as the number of sites with gingival bleeding on probing (BoP) divided by the total number of sites per mouth, multiplied by 100 (%)
Full-mouth plaque score Baseline-3 months-6 months Defined as the number of sites with detectable supragingival dental plaque divided by the total number of sites per mouth, multiplied by 100 (%)
Trial Locations
- Locations (1)
University of Santiago de Compostela
🇪🇸Santiago De Compostela, Spain